Executive Vice President, Investments & CIO
and access,
Navin Jacob is Executive Vice President and Chief investment Officer at DRI Healthcare. Prior to DRI Healthcare he was Senior Equity Research Analyst most recently covering Smid Cap Biotechnology & Large Cap Pharmaceuticals at UBS and before that covering Biotech at Deutsche Bank. Prior to that, Mr. Jacob was an investor covering Global Large Cap Pharmaceuticals at HealthCor Management and US Biotech at Surveyor Capital. Before that, he was on the I.I. #1 ranked Biotech & Pharma team at ISI/Deutsche Bank. Mr. Jacob started his career in Finance/Business Analysis at Pfizer/Pharmacia. Mr. Jacob has a B.A. in Biochemistry from Cornell University.
